Parliamentary questions can be asked by any MSP to the Scottish Government or the Scottish Parliamentary Corporate Body. The questions provide a means for MSPs to get factual and statistical information.
Urgent Questions aren't included in the Question and Answers search. There is a SPICe fact sheet listing Urgent and emergency questions.
Displaying 528 questions Show Answers
To ask the Scottish Government what planning is in place for a potential return to blended learning in schools, and what barriers it has identified that might have to be dealt with to ensure that this is successful.
To ask the Scottish Government how many schools have experienced a COVID-19 outbreak, also broken down by how many (a) have had to temporarily close and (b) school weeks have been lost.
To ask the Scottish Government what plans are in place for extra support for pupils to respond to any new school closures because of COVID-19 and catch up on lost class time.
To ask the Scottish Government which species of wild birds are covered under the provisions of the Animals and Wildlife (Penalties, Protections and Powers) (Scotland) Act 2020 regulating wildlife offences that involve the killing and injuring of wild birds.
To ask the Scottish Government how many school pupils (a) have tested positive for and (b) are self-isolating from COVID-19 following an outbreak at their school.
To ask the Scottish Government, in light of the reported financial problems facing the sector, whether it will provide details of what support it is offering to the coach industry.
To ask the Scottish Government when it will publish its response to the Werritty Review, which examined the effects of grouse moor management on wildlife and the countryside.
To ask the Scottish Government how it is working with SMEs to pursue sustainable and ethical economic growth.
To ask the Scottish Government what the impact of COVID-19 has been on the availability of workers in the rural economy and tourism sectors.
To ask the Scottish Government what provision there is for (a) symptomatic and (b) asymptomatic (i) staff and (ii) patients in COVID-19-free sites where cancer diagnostic tests and treatments take place to be tested for the virus.